Physician

Bahareh Bahadini, MD

According to 2025 Medicare claims, Bahareh Bahadini, MD (NPI: 1295734614) practices medical oncology in the Oxnard-Thousand Oaks-Ventura, CA market, with the plurality of this provider's patient population coming from Ventura, CA. This provider's primary affiliated billing organization is CITY OF HOPE MEDICAL FOUNDATION (NPI: 1871886366; TIN: 274803222) and primary practice location at 91361-5230. Bahadini is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Bahadini's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 391 traditional Medicare patients, billed 162,209 HCPCS/CPT codes, and received $3,063,623 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 486 prescription claims across 114 beneficiaries totaling $1,186,133 in drug costs, led by Ibrance (Palbociclib). DME data shows 24 claims. Open Payments data shows 1 records totaling $88. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,241,127 to $3,063,623. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $439,796 and ending at $1,186,133. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $12,022 to $589.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.1M2015 Medicare payment: $1,241,127 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $942,964 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,469,207 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,500,516 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,278,564 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,983,277 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,134,485 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,266,406 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,821,587 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,063,623 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015301103,337$1,241,127
201627369,718$942,964
2017216113,093$1,469,207
2018243130,941$1,500,516
201926192,439$1,278,564
2020379158,975$1,983,277
2021344160,271$2,134,485
2022367170,876$2,266,406
2023397168,496$2,821,587
2024391162,209$3,063,623

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.3M2015 Drug cost: $439,796 (USD; Tot_Drug_Cst)2016 Drug cost: $696,297 (USD; Tot_Drug_Cst)2017 Drug cost: $1,045,797 (USD; Tot_Drug_Cst)2018 Drug cost: $803,460 (USD; Tot_Drug_Cst)2019 Drug cost: $1,312,553 (USD; Tot_Drug_Cst)2020 Drug cost: $2,270,680 (USD; Tot_Drug_Cst)2021 Drug cost: $854,476 (USD; Tot_Drug_Cst)2022 Drug cost: $1,311,264 (USD; Tot_Drug_Cst)2023 Drug cost: $1,118,215 (USD; Tot_Drug_Cst)2024 Drug cost: $1,186,133 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201585455$439,796
2016108590$696,297
201799682$1,045,797
2018104680$803,460
2019131686$1,312,553
2020139807$2,270,680
2021126556$854,476
2022109594$1,311,264
2023103473$1,118,215
2024114486$1,186,133

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.7K$7.3K2015 Medicare payment: $7,319 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $638 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,903 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,277 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,727 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $5,721 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $729 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R70$7,319
2016N/R15$638
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R47$3,903
2021N/R13$2,277
2022N/R64$2,727
2023N/R38$5,721
2024N/R24$729

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more9191$190
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more221666$156
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more249704$108
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's211416$14
96372Injection of drug or substance under skin or into muscle85328$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib18504$272,439
KisqaliRibociclib Succinate12336$194,737
LynparzaOlaparib13390$129,633
EliquisApixaban20630$12,442
AnastrozoleAnastrozole474,141$1,574

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R12$503
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R12$226

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$88PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Bahareh Bahadini, MD?

Tedicare shows public-source Medicare data for Bahareh Bahadini, MD (NPI 1295734614), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bahareh Bahadini, MD have ACO affiliation data?

Bahareh Bahadini, MD is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Bahareh Bahadini, MD?

Bahareh Bahadini, MD is linked to CITY OF HOPE MEDICAL FOUNDATION (billing NPI 1871886366) in the available physician profile data.

Does Bahareh Bahadini, MD have Open Payments data?

Bahareh Bahadini, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.